August 27, 2016 7:03 PM ET

Capital Markets

Company Overview of Novo Ventures

Company Overview

Novo Ventures is an evergreen fund specializing in investments in any stage of development with a focus on seed capital/ start-ups, early, mid, and late venture investments. It also invests over private placements to IPOs and private and public companies. The fund seeks to make investments in companies involved in development of new drugs; new procedures for the diagnosis and control of diseases; development of medical devices and instruments, industrial biotechnology; life sciences tools and services, vitamins and nutritional supplements, food products; development and application of biotechnology; improvement of food, nutrition and health for humans and animals; and development of sustaina...

Tuborg Havnevej 19

Hellerup,  DK-2900

Denmark

Phone:

45 35 27 65 00

Fax:

45 35 27 65 10

Key Executives for Novo Ventures

Managing Partner
Age: 62
Senior Partner and Non-Executive Director
Age: 60
Partner
Age: 52
Venture Auditor
Compensation as of Fiscal Year 2016.

Novo Ventures Key Developments

Novo Ventures Presents at Medical Device Conference, Jun-24-2016 02:40 PM

Novo Ventures Presents at Medical Device Conference, Jun-24-2016 02:40 PM. Venue: Sharon Heights Golf and Country Club, 2900 Sand Hill Road, Menlo Park, CA, United States. Speakers: Eric Shiozaki.

Novo Ventures Presents at 9th Annual European Life Sciences CEO Forum & Exhibition, Mar-15-2016

Novo Ventures Presents at 9th Annual European Life Sciences CEO Forum & Exhibition, Mar-15-2016 . Venue: Hilton Zurich Airport Hotel, 27 Belsize Lane, London | NW3 5AS, United Kingdom. Speakers: Nanna Luneborg, Principal.

Similar Private Companies By Industry

Company Name Region
aa ejendomme 2 Ap Europe
aa ejendomme A/S Europe
Accunia Credit Management Fondsmaeglerselskab A/S Europe
ACTA / corporate finance Europe
Alm. Brand Formue A/S Europe

Recent Private Companies Transactions

Type
Date
Target
Private Placement
November 23, 2015
ObsEva SA
Merger/Acquisition
November 6, 2015
ZS Pharma, Inc.
Private Placement
September 16, 2015
Corvus Pharmaceuticals, Inc.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Novo Ventures, please visit www.novo.dk/ventures/about. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.